Pegulicianine acetate

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NamePegulicianine acetate
Drug Alias NameLUMISIGHTLUM-015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsPeripheral Arterial DiseaseCarotid Artery DiseasesPancreatic Neoplasms +[7] 
Global Approved IndicationsBreast Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/04/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLumicell Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthLumicell IncNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesN/A
Active IndicationsPeripheral Arterial DiseaseCarotid Artery DiseasesPancreatic Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A